Target intelligence / Profile preview

Host-gut microbiota ecosystem

Molecular classification
Other
01

Overview

The host-gut microbiota ecosystem is a complex symbiotic network comprising trillions of microorganisms, including bacteria, viruses, fungi, and archaea, that reside within the human gastrointestinal tract [1]. This ecosystem functions as a virtual organ, performing vital roles in nutrient metabolism, vitamin synthesis, and the development and regulation of the host immune system [2, 3]. It maintains the integrity of the intestinal barrier and protects against pathogen colonization through competitive exclusion and the production of antimicrobial substances [4]. Disruptions to this delicate balance, known as dysbiosis, are implicated in numerous systemic and localized diseases, such as inflammatory bowel disease (IBD), obesity, type 2 diabetes, and Clostridioides difficile infection [5, 6]. Modern therapeutic strategies target this ecosystem using fecal microbiota transplants (FMT), probiotics, and engineered microbial consortia to restore a healthy microbial state [7]. Additionally, the gut microbiota significantly influences the pharmacokinetics and efficacy of various systemic drugs, including chemotherapeutic agents and immune checkpoint inhibitors [8]. Sources: [1] NIH Human Microbiome Project; [2] O'Hara & Shanahan (2006) EMBO Rep; [3] Belkaid & Hand (2014) Cell; [4] Buffie & Pamer (2013) Nat Rev Immunol; [5] Lynch & Pedersen (2016) NEJM; [6] Turnbaugh et al. (2006) Nature; [7] FDA (2022/2023) Rebyota/Vowst Approvals; [8] Gopalakrishnan et al. (2018) Science.

Other names
Gut microbiomeIntestinal microbiotaGut-host axisCommensal floraGastrointestinal ecosystem
02

Mechanism of action

Modulation of microbial composition and metabolic output (e.g., short-chain fatty acids) to restore host homeostasis and immune regulation.

03

Biological functions

MetabolismImmune response modulationPathogen defenseVitamin synthesisIntestinal barrier maintenanceNeurotransmitter production
04

Disease associations

InfectionInflammationCancerCardiovascular diseaseOther
05

Safety considerations

Risk of systemic infection or bacteremiaTransfer of multidrug-resistant organisms (MDROs)Unintended long-term ecological shiftsVariable patient response due to donor diversity
06

Interacting drugs

Vancomycin

8 more in the full profile.

07

Biomarkers

Shannon diversity indexFirmicutes/Bacteroidetes ratioFecal calprotectinAbundance of Faecalibacterium prausnitziiShort-chain fatty acid (SCFA) levels

Beyond the preview

Go deeper on Host-gut microbiota ecosystem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host-gut microbiota ecosystem.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call